ARTICLE | Clinical News
CX717: Development discontinued
November 8, 2010 8:00 AM UTC
Valeant said it will not pursue further development of BVF-007 to treat respiratory depression. Valeant, which gained the Ampakine through its merger with Biovail Corp. this year, said the program di...